Ind-Swift Laboratories Limited — Board Meeting, 11-08-2025: Outcome of Board Meeting

Ind Swift Laboratories' Board has approved its consolidated financial results for the quarter and financial year ended March 31, 2025. Full-year net profit reached ₹493.68 Cr.

A key development is the amalgamation with Ind Swift Ltd, now effective from August 8, 2025, leading to a ₹465.88 Cr capital reserve. Post-merger, the company allotted ₹14.20 Cr worth of 1% Redeemable Preference Shares, with approved plans for redemption in tranches. Additionally, 15.32 lakh warrants were converted into equity shares, strengthening the capital base. The company is undertaking strategic steps for future growth.